Pure Global AI

International Medical Device Regulators Forum medical device guidance

Official sources linked

Official IMDRF medical device guidance, harmonization frameworks, and source documents.

44 documents9 categories100% linked to official sourcesissuing body IMDRF
CodeRegulationCategoryEffectiveProvenance
GHTF/SG1/N044:2008
Role of Standards in the Assessment of Medical Devices
Guidance on the use of international standards in medical device evaluation. Addresses standards recognition and application in regulatory assessment.
General—Official
GHTF/SG1/N046:2008
Principles of Conformity Assessment for IVD Medical Devices
Conformity assessment principles specific to in vitro diagnostic devices. Addresses IVD-specific evaluation requirements and compliance pathways.
General—Official
GHTF/SG1/N055:2009
Definition of Terms: Manufacturer, Authorised Representative, Distributor, Importer
Standardized definitions for supply chain participants including manufacturer, authorized representative, distributor, and importer roles and responsibilities.
General—Official
GHTF/SG1/N065:2010
Registration of Manufacturers and Listing of Medical Devices
Guidance on manufacturer registration and device listing requirements. Outlines regulatory authority notification procedures and database submission.
Registration—Official
GHTF/SG1/N071:2012
Definition of Terms: Medical Device and IVD Medical Device
Standardized definitions for medical device and in vitro diagnostic medical device. Core terminology document for global regulatory alignment.
General—Official
GHTF/SG1/N77:2012
Principles of Medical Devices Classification
Framework for medical device classification based on risk. Establishes harmonized classification rules considering intended use, duration of contact, and invasiveness.
Classification—Official
GHTF/SG1/N78:2012
Principles of Conformity Assessment for Medical Devices
Foundational guidance on conformity assessment methodology for medical device regulation. Establishes principles for demonstrating product compliance with regulatory requirements.
Registration—Official
GHTF/SG2/N54R8:2006
Global Guidance for Adverse Event Reporting for Medical Devices
Comprehensive guidance on post-market surveillance and adverse event reporting requirements for medical devices. Establishes global harmonized reporting criteria and timelines.
Vigilance—Official
GHTF/SG2/N57R8:2006
Guidance on Content of Field Safety Notices
Guidance on the required content and format of field safety notices (FSN) for medical device recalls and corrective actions. Ensures consistent communication to users.
Vigilance—Official
GHTF/SG2/N87:2012
XML Schema for Electronic Transfer of Adverse Event Data
XML schema specification for electronic transfer of adverse event data between regulatory authorities and manufacturers. Enables standardized vigilance reporting.
Vigilance—Official
GHTF/SG3/N15R8:2005
Risk Management Principles and Activities within a QMS
Integration of risk management principles into quality management systems. Addresses risk-based approach to QMS processes aligned with ISO 14971.
GMP/QMS—Official
GHTF/SG3/N17:2008
Guidance on the Control of Products and Services Obtained from Suppliers
Guidance on supplier control within QMS including supplier qualification, evaluation, and monitoring. Addresses purchased products and outsourced processes.
GMP/QMS—Official
GHTF/SG3/N18:2010
Guidance on Corrective Action and Preventive Action (CAPA) and Related QMS Processes
Comprehensive guidance on CAPA processes within medical device quality management systems. Covers root cause analysis, corrective actions, and preventive measures.
GMP/QMS—Official
GHTF/SG3/N19:2012
QMS Nonconformity Grading System for Regulatory Purposes and Information Exchange
Harmonized system for grading QMS nonconformities during regulatory inspections. Enables consistent evaluation and information exchange between regulatory authorities.
GMP/QMS—Official
GHTF/SG3/N99-10:2004
QMS Process Validation Guidance
Guidance on process validation requirements for medical device manufacturing. Covers IQ, OQ, PQ protocols and ongoing process verification.
GMP/QMS—Official
GHTF/SG5/N5:2012
Reportable Events During Pre-Market Clinical Investigations
Guidance on reporting adverse events and other reportable events during pre-market clinical investigations. Covers reporting criteria, timelines, and procedures.
Clinical Trials—Official
GHTF/SG5/N6:2012
Clinical Evidence for IVD Medical Devices
Guidance on clinical evidence requirements for IVD medical devices. Addresses evidence generation, clinical performance data, and regulatory submission requirements.
Clinical Trials—Official
GHTF/SG5/N7:2012
Scientific Validity Determination and Performance Evaluation
Guidance on establishing scientific validity and conducting performance evaluation for IVD devices. Covers analytical and clinical performance assessment.
Clinical Trials—Official
GHTF/SG5/N8:2012
Clinical Performance Studies for IVD Medical Devices
Guidance on designing and conducting clinical performance studies for IVD devices. Covers study design, statistical considerations, and reporting requirements.
Clinical Trials—Official
IMDRF/SaMD WG/N10:2013
Software as a Medical Device (SaMD): Key Definitions
Key definitions for Software as Medical Device. Foundation terminology document distinguishing SaMD from SiMD.
Software/SaMD—Official
IMDRF/SaMD WG/N12:2014
Software as a Medical Device: Risk Categorization Framework
Framework for SaMD risk categorization based on healthcare situation and significance of information. Foundation for global SaMD regulation.
Software/SaMD—Official
IMDRF/RPS WG/N13:2024 (Ed 4)
IVD Medical Device Regulatory Submission Table of Contents
Standardized table of contents for IVD medical device regulatory submissions. Edition 4 with updated structure for global harmonization.
Registration—Official
IMDRF/SaMD WG/N23:2015
Software as a Medical Device (SaMD): Application of Quality Management System
QMS guidance specific to SaMD including software lifecycle, configuration management, and problem resolution.
Software/SaMD—Official
IMDRF/SaMD WG/N41:2017
Software as a Medical Device (SaMD): Clinical Evaluation
Clinical evaluation guidance for Software as Medical Device. Covers valid clinical association, analytical validation, and clinical validation.
Software/SaMD—Official
IMDRF/AE WG/N43:2025
Terminologies for Categorized Adverse Event Reporting (AER)
Standardized terminologies, terms, and codes for categorized adverse event reporting. Enables harmonized global vigilance data exchange.
Vigilance—Official
Exports carry source + retrieval date
Tracked from official IMDRF publications · row IDs are stable — cite as regulations:imdrf:ghtf-sg1-n044-2008